Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 25

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 25
---
 consider information on our website to be part of this prospectus or in deciding to purchase our common stock.

Offerings Under This Prospectus

Under this prospectus, we may offer shares of our common stock and preferred stock, various series of debt securities and/or warrants or rights to purchase any of such securities, either individually or in units, with a total value of up to $75,000,000, from time to time at prices and on terms to be determined by market conditions at the time of the offering. This prospectus provides you with a general description of the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable:

| ● | designation        
 or classification; |

| ● | aggregate                                     
 principal amount or aggregate offering price; |

| ● | maturity,      
 if applicable; |

| ● | rates                                                  
 and times of payment of interest or dividends, if any; |

| ● | redemption,                               
 conversion or sinking fund terms, if any; |

| ● | voting                       
 or other rights, if any; and |

| ● | conversion                  
 or exercise prices, if any. |

The prospectus supplement also may add, update or change information contained in this prospectus or in documents we have incorporated by reference into this prospectus. However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer a security that is not registered and described in this prospectus at the time of its effectiveness.

We may sell the securities directly to investors or to or through agents, underwriters or dealers. We, and our agents or underwriters, reserve the right to accept or reject all or part of any proposed purchase of securities. If we offer securities through agents or underwriters, we will include in the applicable prospectus supplement:

| ● | the                                    
 names of those agents or underwriters; |

| ● | applicable                                          
 fees, discounts and commissions to be paid to them; |

| ● | details                                       
 regarding over-allotment options, if any; and |

| ● | the                 
 net proceeds to us. |

This prospectus may not be used to consummate a sale of any securities unless it is accompanied by a prospectus supplement.

| 2 |

<div align='center'>RISK FACTORS</div>

Investing in our securities involves significant risk. The prospectus supplement applicable to